Navigation Links
European Pharmaceutical Market: Strategic Assessments of Leading Suppliers
Date:10/5/2011

NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Pharmaceutical Market: Strategic Assessments of Leading Suppliers

http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

• Sales forecast for major product segments: ethical, OTC, generics.

• Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

• To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the European pharmaceutical market.

• To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors.

• To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.

• To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

Contains 1,353 pages and 127 tables

Table of Contents

Abbott

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

AstraZeneca

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Bristol-Myers Squibb

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Eli Lilly

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionGlaxoSmithKline

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Johnson & Johnson

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Merck

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Novartis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionPfizer

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Roche

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Sanofi-Aventis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Wyeth

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionList of Tables

Abbott Sales and Operating Profit Growth

Abbott Sales by Therapeutic Category/Business

Abbott Sales Growth by Therapeutic Category/business

Abbott Sales by Major Drug/Business

Abbott Sales Growth by Major Drug/Business

Abbott Sales by Major Drug/Business and Geographic Region

Abbott Sales by Geographic Region and Country

Abbott Sales Growth by Geographic Region and Country

AstraZeneca Sales and Operating Profit Growth

AstraZeneca Sales by Therapeutic Category/Business

AstraZeneca Sales Growth by Therapeutic Category/business

AstraZeneca Sales by Major Drug/Business

AstraZeneca Sales Growth by Major Drug/Business

AstraZeneca Sales by Major Drug/Business and Geographic Region

AstraZeneca Sales by Geographic Region and Country

AstraZeneca Sales Growth by Geographic Region and Country

Bristol-Myers Squibb Sales and Operating Profit Growth

Bristol-Myers Squibb Sales By Major Drug and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales By Geographic Region

Bristol-Myers Squibb Estimated Sales Growth By Geographic Region

Historical Financials

Bristol-Myers Squibb Sales and Operating Profit growth

Bristol-Myers Squibb Sales by Major Division

Bristol-Myers Squibb Sales by Major Division and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Division

Bristol-Myers Squibb Sales by Therapeutic Category

Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region

Bristol-Myers Squibb Sales Growth by Therapeutic Category

Bristol-Myers Squibb Sales by Major Drug

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales by Product Line

Bristol-Myers Squibb Sales Growth by Product Line

Bristol-Myers Squibb Sales by Geographic Region

Bristol-Myers Squibb Sales Growth by Geographic Region

Bristol-Myers Squibb Other Health Care Sales by Product

Bristol-Myers Squibb Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

Eli Lilly Sales by Therapeutic Category

Eli Lilly Sales Growth by Therapeutic Category

Eli Lilly Sales by Major Product

Eli Lilly Sales Growth by Major Drug

Eli Lilly Sales by Geographic Region

Eli Lilly Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

GlaxoSmithKline Sales by Business Segment

GlaxoSmithKline Sales Growth by Business Segment

GlaxoSmithKline Operating Profit and Margins by Business Segment

GlaxoSmithKline Operating Profit by Business Segment GlaxoSmithKline Sales and Operating Profit Growth

GlaxoSmithKline Sales by Major Drug

GlaxoSmithKline Sales by Drug and Geographic Region

GlaxoSmithKline Sales by Therapeutic Category

GlaxoSmithKline Sales Growth by Therapeutic Category

GlaxoSmithKline Sales by Geographic Region and Country

GlaxoSmithKline Sales Growth by Geographic Region

GlaxoSmithKline Consumer Healthcare Sales by Product Line

GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line

Johnson & Johnson Sales by Geographic Region and Country

Johnson & Johnson Sales Growth by Geographic Region

Johnson & Johnson Sales by Business Segment and Geographic Region

Johnson & Johnson Sales and Operating Profit Growth

Johnson & Johnson Sales by Major Drug

Johnson & Johnson Pharmaceutical Sales Growth by Major Drug

Johnson & Johnson Consumer Segment Sales by Product Line

Johnson & Johnson Consumer Segment Sales Growth by Product Line

Merck Sales and Operating Profit Growth

Merck Sales by Geographic Region

Merck Sales Growth by Geographic Region

Merck Sales by Therapeutic Category

Merck Sales Growth by Therapeutic Category

Merck Sales by Major Drug

Merck Sales Growth by Major Drug

Merck Sales by Major Drug and Geographic Region

Novartis Sales and Operating Profit Growth

Novartis Sales by Business Segment

Novartis Sales Growth by Business Segment

Novartis Operating Profit by Business Segment

Novartis Operating Profit Growth by Business Segment

Novartis Sales by Country

Novartis Sales Growth by Country

Novartis Sales by Therapeutic Category

Novartis Sales Growth by Therapeutic Category

Novartis Sales of Top 20 Drugs

Novartis Sales Growth by Major Drug

Pfizer Sales by Division

Pfizer Sales and Operating Profit Growth

Pfizer Sales by Therapeutic Category

Pfizer Sales by Major Product

Pfizer Sales Growth by Major Product

Pfizer Sales by Geographic Region

Pfizer Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Major Division

Roche Sales Growth by Business Segment

Roche Sales by Geographic Region

Roche Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Division

Roche Operating Profit by DivisionRoche Operating Profit Growth by Division

Roche Sales by Therapeutic Category

Roche Sales of Top 20 Products

Sanofi-Aventis Sales and Operating Profit Growth

Sanofi-Aventis Sales by Business Segment

Sanofi-Aventis Sales Growth by Business Segment

Sanofi-Aventis Sales of Top 15 Drugs

Sanofi-Aventis Sales Growth of Top 15 Drugs

Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region

Sanofi-Aventis Sales by Geographic Region

Sanofi-Aventis Vaccine Sales by Major Product

Wyeth Sales by Business Segment

Wyeth Sales Growth by Business Segment

Wyeth Sales and Operating Profit Growth

Wyeth Sales by Therapeutic Category

Wyeth Sales by Major Drug

Wyeth Consumer Healthcare Sales by Product

Wyeth Consumer Healthcare Sales Growth by Product

To order this report:

Drug and Medication Industry: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers

Drug and Medication Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016  Licenders is bringing their 100% all-natural lice removal service ... Slope at 203 13 th Street was specifically chosen to ... "Our goal is to ease parents, stress and bring ... get children right back to class without skipping a beat. The ... safe for the whole family," Licenders President Adie Horowitz ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
(Date:12/6/2016)... -- Human Vaccines Market: Scope and Methodology ... wise analysis of the human vaccines market. Stakeholders ... products, raw material suppliers, vaccine processing companies, and ... The report provides qualitative and quantitative analysis of ... market dynamics, trends, product overview, and country-level market ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 06, 2016 , ... The International Vaccine Institute (IVI) and ... the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine ... deployment in the event of a future outbreak. , IVI and GeneOne held ...
(Date:12/6/2016)... ... 2016 , ... According to a November 1 article published on ... or not drinking enough water, which can cause bad breath (known medically as halitosis). ... oral hygiene not only helps reduce the possibility of bad breath, but it can ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... for population health management, announces today a strategic relationship with CitiusTech, a ... clinical rules engine that offers advanced Clinical Quality Measures (CQM) computation capabilities ...
(Date:12/6/2016)... ... December 06, 2016 , ... In anticipation for the New Year, ... availability of continuing education courses in 2017, dentists of all levels can continue to ... in January, dentists can attend a variety of continuing education courses each month on ...
(Date:12/6/2016)... ... ... Why does the prevalence of obesity continue to increase worldwide? Some would say ... the cause of obesity in his new book “Body Weight Regulation.” , “Body ... a healthy life. Proietto said understanding the regulation of body weight and the causes ...
Breaking Medicine News(10 mins):